Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
|
Your cart is empty |
|||
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases > HIV / AIDS
This book provides a comprehensive review of the major barriers to HIV cure and vaccine. It covers the fundamental virology and immunology leading to HIV transmission, protection from infection and long term HIV persistence on antiretroviral therapy. In addition, strategies being tested to eliminate persistent HIV and the rational design of vaccines to induce protective immunity are covered. This book also discusses the challenges related to the design of clinical trials for testing the safety and efficacy of these innovative approaches. This book will provide a systematic overview and also discuss controversial issues for researchers in virology and immunology, as well as practicing physicians, and scientists in the pharmaceutical industry.
Written by a team of nationally recognized African American social work professionals with extensive and distinguished backgrounds of HIV/AIDS service, the book examines the crisis facing African American communities. The editors strive to convey to academics, researchers, and students the magnitude of the crisis and that individuals and organizations serving African Americans need to be able to respond to the service delivery needs this crisis brings. The crisis is evident in the fact that by year 2000 fully 50% of all AIDS cases will be among African Americans--who only constitute 12% of the nation's population. This book serves as a wake-up call and is designed to stimulate discussion and planning for new models of service to all African Americans and HIV prevention, education, and treatment.
"It has long been a belief of the feminist academic community that personal voices and experiences must be validated and heard. This volume succeeds admirably in being true to that tradition."--"Canadia HIV/AIDS Policy and Law Newsletter" Women now account for the majority of all new HIV/AIDS cases diagnosed in the United States. Yet, the resources allotted to women for research, health services, education, and outreach remain woefully inadequate. The Gender Politics of HIV/AIDS in Women fills crucial gaps in understanding the specific effects of HIV and AIDS on and in women's lives. It takes as its starting point the premise that it is vitally important for researchers, teachers, health service providers, public policy makers, and community-based organizers to begin taking gender-- especially as it intersects with race, class, and sexuality-- into consideration as they work with HIV-infected women. The first comprehensive, interdisciplinary volume on this topic, The Gender Politics of HIV/AIDS in Women goes beyond tokenism, with a contributor's list made up of approximately 45% people of color, including African Americans, Latinos/as, Asian Americans and Pacific Islanders, and Native Americans. The volume emphasizes marginalized populations such as the homeless, sexworkers, youth, the elderly, intravenous drug users, transgendered people, lesbians, bisexuals, incarcerated women, and victims of sexual abuse and domestic violence. The contributors, including Evelyn Hammonds, Risa Denenberg, Michelle Murrain, and Paul Farmer, are recognized experts in their diverse fields. From their posts at the center of the pandemic--in the laboratory, the academy, clinics, and communitybased organizations--they criticize blind spots in the recognition and treatment of HIV in women and articulate accessible and practical solutions to specific areas of difficulty.
This book on NeuroAIDS, a collection of chapters written by experts and specialists from around the world, provides a global perspective on HIV and NeuroAIDS in the field, clinic, and laboratory. The chapters address the comorbidity of HIV and other infectious agents, including Zika virus, Ebola, Chagas disease, TB and HCV. Also discussed are key topics, such as: * Molecular socioepidemiology * Global HIV and NeuroAIDS * Neuropathology * cART and blood-brain barrier penetration * HIV replicative oscillations * HIV and SIV evolution * Psychiatric comorbidities * Neurosyphilis * The examination of current and innovative models of translational research to translational effectiveness
The Deep South has seen a 36 percent increase in AIDS cases while the rest of the nation has seen a 2 percent decline. Many of the underlying reasons for the disease's continued spread in the region-ignorance about HIV, reluctance to get tested, non-adherence to treatment protocols, resistance to behavioral changes-remain unaddressed by policymakers. In this extensively revised second edition, Kathryn Whetten and Brian Wells Pence present a rich discussion of twenty-five ethnographic life stories of people living with HIV in the South. Most importantly, they incorporate research from their recent quantitative study, "Coping with HIV/AIDS in the Southeast" (CHASE), which includes 611 HIV-positive patients from North Carolina, South Carolina, Georgia, Alabama, and Louisiana. This new edition continues to bring the participants' voices to life while highlighting how the CHASE study confirmed many of the themes that originally emerged from the life histories. This is the first cohesive compilation of up-to-date evidence on the unique and difficult aspects of living with HIV in the Deep South.
The AIDS Pandemic explores the ways in which HIV/AIDS has, and
continues to transform the wide range of related disciplines it
touches. Novel perspectives are provided by a unique panel of
internationally recognised experts who cover the unprecedented
impact onf AIDS on culture, demographics and politics around the
world, including how it affected the worlds' economy, health
sciences, epidemiology and public health. This important far-
reaching analysis uses the lessons learned from a wide array of
disciplines to help us understand the current status and evolution
of the pandemic, as it continues to evolve.
This annotated work represents the first bibliography since the AIDS epidemic began to unite scientific literature about prostitutes. The annotated entries cover works on prostitutes published in English in both major and obscure bio-medical journals between 1900 and 1990, and include literature concerning the relationship between prostitutes and AIDS. Some papers published in European and Asian languages are also included. The entries were compiled from published, original papers and other types of editorial material in scientific journals, abstracts, books and chapters, doctoral dissertations, and research reports from agencies and commissions. Significant literature on the relationship between prostitution and AIDS is covered. Of the 1,440 entries, 226 are from non-English language sources. This reference work will be valuable to professionals in the medical and social sciences, law enforcement, psychology, public health, anthropology, and women's studies.
In this extraordinary history, James Driscoll reveals the untold story of how AIDS activists, by thwarting bureaucratic plans imposed by the U.S. Federal Drug Administration (FDA), both saved HIV patients and rescued the FDA itself from a self-inflicted public health catastrophe. By 1996, accelerated approval of AIDS drug cocktails transformed AIDS from a death sentence to a manageable disease. That approval, however, came only after years of struggle pitting AIDS activists against the hidebound culture of the Food and Drug Administration, which wanted to run lengthy efficacy trials required for full approval and possibly delay the drugs at a cost of tens of thousands of lives. Driscoll's courageous efforts, which are an important personal part of the story, navigated conflicts among AIDS activist groups as they struggled with both major American political parties to be heard and respected. He examines the effect of AIDS activism on the LGBT community, its views of itself, and its place in modern American society. Additional materials analyze FDA mistakes, drug pricing, and other contemporary challenges for the LGBTs community.
Every 14 seconds a Child Headed Household is formed
The result of an intensive two-year research study, this volume examines the likely course of the AIDS epidemic over the next fifteen years. Extremely well-documented and based largely on sophisticated statistical analysis, the study makes detailed forecasts of who will become sick; explores the social, political, and economic consequences of the spread of the disease; and analyzes the controversial policy choices that must be made if the epidemic is to be contained. The authors argue that current policies have failed in their efforts to combat the spread of AIDS and suggest new public policy measures aimed at dramatically reducing the spread of the virus. AIDS researchers, health care practitioners, and policymakers will find The Catastrophe Ahead both an invaluable source of detailed statistical information about the AIDS epidemic and an urgent call to action. Based on the study results, the authors conclude that by 2002, a million and a half people may die of AIDS and more than 4 million others may be infected with the disease. They explore various scenarios--worst, best, and middle cases--demonstrating that blacks face by far the greatest risks: under the most likely scenario some 15 percent of all blacks between the ages of 15 and 50 will carry the virus by 2002. The authors propose a universal routine voluntary testing program to avert this catastrophe, enabling people to sexually self-segregate themselves based on whether or not they carry the HIV virus. While the authors concede that this program cannot completely stem the tide of infection, they argue that it offers one of the best defenses available against the epidemic. Well written and illustrated with numerous tables and figures, this volume should be required reading for anyone involved in AIDS counseling and policymaking.
An estimated 17 million people are infected with HIV today, and it is estimated that in Africa alone there will be at least 70 million people infected in the next 25 years. This global pandemic has already had a profound impact economically and socially in terms of expensive research, care centers, and immeasurable loss of many of the world's most talented people. Sexual relations, health care of non-infected individuals, family relations, and other social institutions have been significantly marked by this elusive and to date life-threatening phenomenon. Topics range from breastfeeding to condom use, from apathetic governments to immigration policy. Dr. Feldman and his contributors evaluate various policies that have been proposed or adopted on four continents and provide a needed perspective on planetary problems.
This book tells the story of the HIV epidemic in South Africa, and asks why, after more than three decades, it has not normalised. Despite considerable efforts to prevent infection, and ambitious targets set to end the epidemic by 2030, HIV infections are increasing among young women and treatment uptake and adherence have been uneven. Focusing on the years preceding and following treatment access, this book addresses why an end to AIDS may be misplaced optimism. By examining public discourses and private narratives about infection, illness and death, this work reveals the contradictions between the lived experiences of AIDS suffering on the one hand, and biomedical certainties on the other. Based on long-term ethnographic research in rural villages of the South African lowveld, and within HIV prevention interventions in South Africa more generally, this book offers an intimate perspective on the social and cultural responses to the epidemic.
For young gay men who came of age in the United States in the 1980s, the HIV/AIDS epidemic was a formative experience in fear, hardship, and loss. Those who were diagnosed before 1996 suffered an exceptionally high rate of mortality, and the survivors - both the infected individuals and those close to them - today constitute a "bravest generation" in American history. The AIDS Generation: Stories of Survival and Resilience examines the strategies for survival and coping employed by these HIV-positive gay men, who together constitute the first generation of long-term survivors of the disease. Through interviews conducted by the author, it narrates the stories of gay men who have survived since the early days of the epidemic; documents and delineates the strategies and behaviors enacted by men of this generation to survive it; and examines the extent to which these approaches to survival inform and are informed by the broad body of literature on resilience and health. The stories and strategies detailed here, all used to combat the profound physical, emotional, and social challenges faced by those in the crosshairs of the AIDS epidemic, provide a gateway for understanding how individuals cope with chronic and life-threatening diseases. Halkitis takes readers on a journey of first-hand data collection (the interviews themselves), the popular culture representations of these phenomena, and his own experiences as one of the men of the AIDS generation. This riveting account will be of interest to health practitioners and historians throughout the clinical and social sciences - or to anyone with an interest in this important chapter in social history.
The Reverse Transcriptase (RT) of Human Immunodeficiency Virus Type 1 (HIV-1) arguably ranks amongst one of the most extensively studied retroviral enzymes. Heterologous expression and purification of HIV-1 RT in the early eighties, approval of the first nucleoside analogue RT inhibitor (NRTI) in 1987, discovery of resistance to RT inhibitors, approval of the first non-nucleoside analogue RT inhibitor (NNRTI) in 1996 and the various crystal structures of RT with and without bound substrate(s) and/or inhibitors represent only a few of the important milestones that describe the a bench-to-bedside success in the continuing effort to combat HIV-1 infection and its consequences. Nucleoside and nonnucleoside RT inhibitors remain important components in frequently used drug regimens to treat the infection. RT inhibitors also play important roles in recently validated strategies to prevent transmission of the virus. The relevance of HIV-1 RT as a drug target has simultaneously triggered interest in basic research studies aimed at providing a more detailed understanding of interactions between proteins, nucleic acids, and small molecule ligands in general terms. In light of the ever-growing knowledge on structure and function of HIV-1 RT, this enzyme serves as a valuable "model system" in efforts to develop novel experimental tools and to explain biochemical processes. This monograph is designed to provide an overview of important aspects in past and current HIV-1 RT research, with focus on mechanistic aspects and translation of knowledge into drug discovery and development. The first section includes chapters with emphasis placed on the coordination of the RT-associated DNA polymerase and ribonuclease H (RNase H) activities. The second covers mechanisms of action and future perspectives associated with NRTIs and NNRTIs, while the third section includes chapters focusing on novel strategies to target the RT enzyme. Chapters of the final part are intended to discuss mechanisms involved in HIV variability and the development of drug resistance. We hope that these contributions will stimulate interest, and encourage research aimed at the development of novel RT inhibitors. The lack of bona fide RNase H inhibitors with potent antiviral activity provides an example for challenges and opportunities in the field.
Intravenous drug users account for nearly one-third of the current AIDS cases in the United States--second only to gay males--and are responsible for 72 percent of female and 59 percent of pediatric cases of AIDS. Thus the National Institute of Drug Abuse launched a major effort in 1987 to locate hidden users and to see how they function and to evaluate strategies and community-based programs in 50 cities and 60 nearby communities around the country in order to lower risks to IV users and to reduce the dangers that they pose to others in the population. Brown and Beschner present the very latest findings and come to well-tested conclusions about how to change behaviors positively. This handbook is written for use in college, university, and professional libraries and for students, teachers, policymakers, and practitioners in public health service and in public policy at all governmental levels to study carefully. Brown and Beschner open with an introduction showing how injection drug users and their sexual partners are at risk for aids. Part I describes the spread of AIDS in the United States and Puerto Rico. Part II depicts patterns of injection drug and crack use and their effect on sex partners. Part III deals with gender issues. Part IV goes into demographic and background factors. Part V discusses key issues in the use of drug abuse treatment. Part VI analyzes outreach and behavior change strategies. And Part VI looks into how risk can be reduced as a result of outreach and specific intervention strategies. The final chapter comes to some conclusions about the effectiveness of various interventions by the National AIDS Demonstration Research Project. Background readings also add to the importance of this major reference.
Miletich provides a survey of information published between 1983 and 1993. Part One is a chronological listing of information which illustrates how information about AIDS has evolved annually and in which form this information appears. There are, for each year, up to 12 categories, ranging from books to videocassettes, government documents to atlases, conference proceedings to review papers. Selected annotations elaborate on this information. Part Two is an annotated bibliography about occupations at increased risk of contracting AIDS. Part Three consists of appendices. In addition the book contains a list of acronyms, and separate author and subject indexes. With some 1200 items and with its international scope, AIDS provides information accessible to students and researchers from grade school onward. Information about publications devoted exclusively to AIDS, AIDS organizations in various countries, and an AIDS time-line illustrate that this book is intended for virtually any person concerned about AIDS.
This edited collection shows how the spread of HIV infection has been followed, represented, and managed in nine countries between 1982 and 1988. The countries cited in this study have been chosen to emphasize contrasts in the social and epidemiological profiles of AIDS, and to suggest the diversity of the problems constituted by HIV/AIDS in different national contexts. The juxtaposition of sequences of national response will raise questions about the range of policy options actually available to political and social policy-makers in a given context, and will invite further examination of the factors determining the acceptance or rejection of specific measures. Following the introduction, which outlines the choices that national governments confront in formulating AIDS policies, the successive chapters cover the reactions to HIV/AIDS in the United States, Brazil, France, Belgium, West Germany, Italy, Poland, Australia, and Africa. The final chapter compares the patterns of national response, identifies their common and divergent features, and points out tensions in policy-making caused by current changes in the spread of infection and in the understanding of the virus. This book makes informative reading for those who want to learn more about international variation in the political, social, and economic aspects of the AIDS epidemic.
This book addresses the impact of HIV on populations of men who have sex with men in Africa and local responses to the issue. It documents the enduring existence of a rich variety of same-sex practices between men. More critically, it analyses how the denial and social rejection of same-sex sexuality, together with the legacy of criminalization by former colonial rulers, has not only fueled the transmission of HIV between men, but has also impeded an effective response. The book also documents some of the outstanding progress that has been made and acknowledges the differences between African countries. Through its focus on lived realities and grassroots activism in Africa, this book will appeal to researchers, policy makers and practitioners alike.
Is There a Link between the Nature of Agents That Trigger Mast Cells and the Induction of Immunoglobulin (IG)E Synthesis?.- Immunogenetic Aspects of IgE-Mediated Responses.- Structure and Function of the Low Affinity IgE Receptor.- Characterization of the Human IgE Fc-Fce RIa Interaction.- The Analysis of Mast Cell Function in Vivo Using Mast Cell-Deficient Mice.- The Immunogenetic Basis of Collagen Induced Arthritis in Mice: An Experimental Model for the Rational Design of Immunomodulatory Treatments of Rheumatoid Arthritis.- Suppression of Experimental Autoimmune Myasthenia Gravis by Epitope-Specific Neonatal Tolerance.- T Cell Reactivity to Self and Allogeneic MHC-Peptides.- Antiribosomal Antibodies in SLE, Infection, and Following Deliberate Immunization.- Cross-Reactions of Anti-Immunoglobulin Sera with Synthetic T-Cell Receptor ? Peptides: Mapping on a 3-Dimension Model.- Stress Proteins in Autoimmunity.- Polyclonal B Cell Activation and B Cell Cross-Reactivity During Autoantibody Production in Systemic Lupus Erythematosus.- Autoantibody Activity and V Gene Usage by B-Cell Malignancies.- Naturally Occurring Human Autoantibodies to Defend T-Cell Receptor and Light Chain Peptides.- Natural Autoantibodies.- Regulatory Autoantibody and Cellular Aging and Removal.- B-Cell Origin of Cold Agglutinins.- Initiation of Autoimmune Type 1 Diabetes and Molecular Cloning of a Gene Encoding for Islet Cell-Specific 37KD Autoantigen.- Mapping of the Polypeptide Chain Organization of the Main Extracellular Domain of the ?-Subunit in Membrane-Bound Acetylcholine Receptor by Anti-Peptide Antibodies Spanning the Entire Domain. |
You may like...
Neurocognitive Complications of…
Lucette A. Cysique, Sean B. Rourke
Hardcover
R5,680
Discovery Miles 56 800
|